Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-060939

Director acquired 3,086 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
AZAB MOHAMMAD Director 2022-12-12 Option exercise +3,086 $2.68 $8,270 69,905 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
AZAB MOHAMMAD Director 2022-12-12 Option exercise · Stock Option (Right to Buy) −3,086 0 D: show line 2 in the form
Loading xslF345X03/doc4.xml…